(Q47614689)

4 February 2018

reason for preferred rank

title

Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients1 (English)

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

12 March 2024

Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501860

12 March 2024

1 reference

Arjang Djamali

1

1 reference

4 February 2018

Nalinee Premasathian

5

1 reference

4 February 2018

Yolanda T. Becker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501860

12 March 2024

William D. Simmons

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501860

12 March 2024

Curtis A. Johnson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501860

12 March 2024

Bryan N. Becker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501860

12 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 February 2018

15 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14501860

12 March 2024

1 reference

4 February 2018

volume

76

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

816-820

1 reference

4 February 2018

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Manifestations of oxidant stress in uremia

12 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors

12 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy

12 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study

12 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study

12 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Cardiovascular disease risk factors in chronic renal insufficiency.

12 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery

12 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Poor long-term survival after acute myocardial infarction among patients on long-term dialysis

12 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis

12 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Erythropoietin therapy may retard progression in chronic renal transplant dysfunction

12 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Effect of anaemia and cardiovascular disease on surgical mortality and morbidity

12 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Role of anaemia in cardiovascular mortality and morbidity in transplant patients

12 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Prevalence and management of anaemia in transplant patients

12 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?

12 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

In-hospital and long-term mortality in male veterans following noncardiac surgery. The Study of Perioperative Ischemia Research Group

12 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Serum erythropoietin levels after renal transplantation

12 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Benefits and concerns of treating pre-dialysis and renal transplant patients with recombinant human erythropoietin

12 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease.

12 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/01.TP.0000084872.26360.C5

12 March 2024

Identifiers

1 reference

4 February 2018

1 reference

4 February 2018